Federated Hermes’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-19,191
| Closed | -$17.5K | – | 2120 |
|
2025
Q1 | $17.5K | Buy |
19,191
+14,095
| +277% | +$12.8K | ﹤0.01% | 1745 |
|
2024
Q4 | $14.1K | Buy |
+5,096
| New | +$14.1K | ﹤0.01% | 1805 |
|
2023
Q1 | – | Sell |
-1,381
| Closed | -$1.45K | – | 2185 |
|
2022
Q4 | $1.45K | Sell |
1,381
-152
| -10% | -$160 | ﹤0.01% | 2030 |
|
2022
Q3 | $4K | Buy |
+1,533
| New | +$4K | ﹤0.01% | 1911 |
|
2022
Q2 | – | Sell |
-451
| Closed | -$2K | – | 2221 |
|
2022
Q1 | $2K | Buy |
451
+330
| +273% | +$1.46K | ﹤0.01% | 2027 |
|
2021
Q4 | $1K | Buy |
+121
| New | +$1K | ﹤0.01% | 2121 |
|